Dexcom launches first over-the-counter continuous glucose monitor. Here’s what it’s like
User wearing Stelo CGM from Dexcom.
Courtesy of Dexcom
Dexcom on Monday announced its new over-the-counter continuous glucose monitor Stelo is officially available for purchase in the U.S.
Glucose is a type of sugar people receive from food, and it’s the body’s main source of energy. Continuous glucose monitors, or CGMs, are small sensors that poke through the skin to measure glucose levels in real time. They are typically prescribed to patients with diabetes since they can help alert users, their loved ones and their doctors to emergencies.
Stelo is primarily intended for patients with prediabetes or Type 2 diabetes who do not use insulin, though individuals without either condition can also purchase it. Users can buy a one-month supply online for $99, or sign up for an ongoing subscription at $89 a month.
Dexcom said patients also have the option to use their flexible spending accounts and health savings accounts to pay for Stelo, according to a statement.
The company already offers continuous glucose monitors for Type 1 and Type 2 diabetes patients, but Stelo is Dexcom’s first product that does not require a prescription. While most Type 1 patients can already get insurance coverage for the sensors, Stelo is now accessible to millions of Type 2 patients who have been unable to get prescriptions or coverage. It also marks the company’s official foray into a new and potentially lucrative prediabetes market.
Dexcom said there are more than 125 million Americans with prediabetes or Type 2 diabetes not using insulin, according to a statement. The company designed Stelo to help teach this patient population how to keep their glucose levels within a healthy range.
“The idea is to help people, over time, learn about diet choices and habits, and how those are impacting glucose,” Jake Leach, chief operating officer at Dexcom, told CNBC in an interview. “It’s about uncovering things you haven’t seen before and then using that to create healthier habits.”
How it works
The U.S. Food and Drug Administration approved Stelo in March. It was the first over-the-counter continuous glucose monitor to be cleared for use, though Dexcom’s competitor, Abbott, received clearance for two similar devices in June.
Leach said Dexcom is working with Amazon to fulfill Stelo deliveries. Users with a subscription can choose to skip or adjust their delivery date, but it will typically be scheduled at the 30-day interval from their initial sign-up.
Stelo is worn on the upper arm and lasts for 15 days before it needs to be replaced. It’s gray, about the size of a quarter and around half an inch thick.
The sensor wirelessly transmits data to a smartphone app. When users are getting set up, they’ll select whether they have Type 2 diabetes, prediabetes or none of the above. This helps establish their “Target Range,” which is where Dexcom wants users to try and keep their glucose levels. The target range is based on established medical standards, and most people fall between 70 and 180 milligrams per deciliter, according to the American Diabetes Association.
When they open the Stelo homepage, they’ll see their latest reading, which is updated every 15 minutes. They’ll also see a graph of their readings each day, which includes a shaded green area to indicate the target range. If they scroll down, they’ll see a summary of the time spent in the target range over time.
Everyone’s glucose levels are variable, but Stelo will send users a notification when they are experiencing a substantial spike. Glucose spikes occur when the amount of sugar present in the bloodstream rapidly increases and then decreases. This often happens after eating.
In the short term, spikes can cause feelings of fatigue, but high glucose levels can lead to more serious health problems like diabetes, heart disease and kidney disease over time, according to the Centers for Disease Control and Prevention. This is why Dexcom wants users to try and keep their levels within Stelo’s target range.
The tab next to the home page is the “Events” page, which is where Stelo users can log meals, activity, fingersticks or other notes. Leach said it’s most important for users to log an entry when they’re experiencing a big spike so that they can reflect on what might be causing it.
Stelo notifies users about noteworthy spikes, so they won’t necessarily get alerted every time their levels rise. Leach said this is an intentional design choice that’s meant to call attention to the larger swings that patients experience.
“Even for someone who has normal glucose and the occasional spike, it’ll look for the most impactful spikes and then try to engage the user around, ‘OK, what happened there?'” he said.
And for users who want to dig deeper into their glucose and understand what causes spikes, there’s a trove of educational materials in the app’s “Learn” tab. The articles are brief, sometimes only a few sentences, and they’re broken down into categories like “Stelo Basics,” “Glucose Deep Dive,” “Nutrition,” “Exercise,” “Sleep” and “Stress.”
CNBC Tests Stelo
The Stelo app
Courtesy of Dexcom
I’ve been testing Stelo since early August. On the whole, I think it’s been easy and helpful to use.
When my monitors arrived in the mail, the first order of business was applying the sensor to my arm and pairing it with the Stelo app. I found this process very straightforward – the app walked me through what to do with clear, step-by-step instructions.
I cleaned the back of my right arm, placed Dexcom’s applicator there, pressed the button and popped the CGM right on. It happens fast and doesn’t hurt at all.
The monitor connects to the Stelo app via Bluetooth, and then it takes about a half hour to warm up.
This is where I initially encountered some problems. Once my device had warmed up, I got an error message that said “Brief Sensor Issue.” The message told me not to take off the CGM, and that the issue was temporary. I left it on for the day, but by evening, I noticed some light bleeding. I decided to take that sensor off.
I applied another CGM to my other arm, and that one warmed up and worked correctly. I’ve been wearing it ever since and haven’t had any trouble with bleeding. Leach said if users have problems with the product, they can message the chat interface on Stelo’s website to get a replacement or answer their questions there.
Once I was all up and running with my second sensor, it was smooth sailing.
I’ve found the Stelo app simple and easy to use. I never felt like I was being overloaded with too much data or too many notifications, and logging meals and exercise is very straightforward. Users can also choose to import their sleep and activity data from the Apple Health app or Android’s Health Connect app, which I think is a nice touch.
If it’s your first time using a CGM, I definitely recommend reading through the articles in the “Learn” tab. I think Dexcom does a good job using plain language to explain what glucose is, what affects it and why it matters.
The longer I wear the sensor, the more I can tell that the algorithm is tuning to me and my habits. I don’t get notifications each time my glucose spikes, but it does alert me when I’m experiencing a particularly substantial jump. The app is also beginning to pick up on my patterns. For instance, it recently told me that my glucose tends to spike between 5 p.m. and 7 p.m., which is usually around when I eat dinner.
Most of the time, I forget I’m even wearing a sensor. It’s waterproof, so I didn’t need to worry about it in the shower. And I didn’t notice it when I was sleeping. I’d advise a little caution when pulling on long sleeves, as the sensor can snag a bit, but it’s easy to wear all types of clothes and jackets over it.
In the short time I’ve been using Stelo, I’ve learned a lot about how my body responds to certain foods. Even small adjustments (eating carbs last, for instance) helped me reduce spikes. It’s easy to see how CGMs can serve as a valuable window into the body. If you’re looking for a simple, approachable entry to understanding your glucose data, I think Stelo is a solid option.
The Blue Ghost Mission Operations Engineer, Jaxon Liebeck, showcases the Blue Ghost moon lander at Firefly Aerospace headquarters on Tuesday, Dec. 3, 2024 in Cedar Park.
Houston Chronicle/hearst Newspapers | Hearst Newspapers | Getty Images
Firefly Aerospace priced shares in its IPO at $45 on Wednesday, above its expected range.
The Texas-based rocket maker will debut on the Nasdaq Thursday under the ticker symbol “FLY.” The offering raised $868 million and values the company at about $6.3 billion.
Firefly filed its initial prospectus in July and upped its IPO range this week to $41 to $43 a share, from an initial range of $35 to $39.
The space technology sector has seen rising investor interest over the last few years as billionaire investors such as Elon Musk and Jeff Bezos put their money behind SpaceX and Blue Origin, respectively.
So far this year, space technology companies Voyager Technology and Karman Holdings have gone public.
The broader IPO landscape has also seen major public debuts this year from Figma, CoreWeave and Circle as the market for public offerings reopens following a prolonged drought.
Technology
Apple and Trump detail $100 billion U.S. spending expansion, including $2.5 billion for an iPhone glass factory
U.S. President Donald Trump speaks as Apple CEO Tim Cook gestures, as they present Apple’s announcement of a $100 billion investment in U.S. manufacturing, while U.S. Treasury Secretary Scott Bessent and Commerce Secretary Howard Lutnick stand in the Oval Office at the White House in Washington, D.C., U.S., August 6, 2025.
Jonathan Ernst | Reuters
Apple CEO Tim Cook and President Donald Trump on Wednesday announced that the iPhone maker will spend an additional $100 billion on U.S. companies and suppliers over the next four years.
The company said its investment would incentivize overseas companies to buy more U.S.-made parts. The commitment is on top of a $500 billion announcement that Apple made in February.
“This is the largest investment Apple has ever made in America and anywhere else,” Trump said. “As you know, Apple has been an investor in other countries a little bit, I won’t say which ones, but a couple, and they’re coming home.”
Trump said that he expects new U.S. factories to be built soon based on his policies.
“There are a lot of factories and a lot of plants that are either under construction or soon we’ll be starting construction,” Trump said. “So can’t tell you exactly when, but I want to be around a year from now.”
Apple on Wednesday said it created the so-called American Manufacturing Program that includes Corning, Coherent, GlobalWafers, Applied Materials, Texas Instruments, Samsung, GlobalFoundries, Amkor and Broadcom.
The company said it would spend $2.5 billion to fund a major expansion with Corning, which makes glass for iPhones in Kentucky. Apple said that all glass for iPhones and Apple Watches will be manufactured in the U.S. at Corning’s facility.
A gift given by Apple CEO Tim Cook to U.S. President Donald Trump stands on President Trump’s table, as they present Apple’s announcement of a $100 billion investment in U.S. manufacturing, in the Oval Office at the White House in Washington, D.C., U.S., August 6, 2025.
Jonathan Ernst | Reuters
At the White House, Cook presented Trump with a souvenir based on Corning’s glass.
Apple also said it had a multiyear supply agreement with Coherent to produce lasers for the iPhone’s facial recognition system.
The company said its U.S.-based supply chain would produce more than 19 billion chips for its products this year. That’s including chips made by TSMC in Arizona, Apple said. It also includes U.S.-made wafers from GlobalWafers and chips from Texas Instruments.
Apple said it would collaborate with Texas Instruments to install additional tools in factories in Utah and Texas. GlobalFoundries, a U.S.-based foundry that manufactures older chips particularly for the U.S. government, will manufacture wireless charging technology in New York for Apple.
The iPhone maker said its goal was to have an “end-to-end” supply chain, which means that every part of the chipmaking process can take place on American soil.
Earlier this year, Apple said it would invest $500 million in a rare earths miner and that it would build AI servers at a factory in Texas.
“Oh, I love that you’re doing this,” Trump said after reading a list of Apple’s announcements.
“President Trump shared some kind words about that work, but he also asked us to think about what more we could commit to doing,” Cook said about Apple’s earlier initial $500 billion commitment. “Mr. President, we took that challenge very seriously.”
Trump has criticized Apple and Cook for not making its smartphones in the U.S., a move that Apple has never signaled that it is likely to make. Experts say that moving production of a high-volume, complicated electronics product like the iPhone to the U.S. would be economically infeasible and could take years.
When asked about the possibility of making the iPhone in the U.S. on Wednesday, Cook said that many of the parts inside the device were made in the U.S.
“If you look at the bulk of it, we’re doing a lot of the semiconductors here, we’re doing the glass here, we’re doing the face ID module here,” Cook said.
Not Apple’s first U.S. commitment
Apple has made similar announcements in the past. In 2018, under pressure during the first Trump administration, Apple committed to spend $350 billion in the U.S. over five years, or about $70 billion per year. In 2021, Apple announced plans to spend $430 billion over five years, or $86 billion per year in the U.S. Wednesday’s announcement has the company at $600 billion over four years, or $125 billion per year.
Much of what Apple has announced has come to fruition, although the company doesn’t report its U.S. spending on an annual basis and suppliers generally don’t break out how much revenue comes from Apple.
The company also faces increased tariffs that could hurt its profits. It’s currently paying for tariffs placed on Chinese imports earlier this year, and faces increased import taxes on semiconductors when the Trump Administration finishes a so-called Section 232 investigation.
Trump said on Wednesday that he planned to impose a 100% tariff on semiconductors and chips, but that Apple was exempt because it is committing to build in the U.S.
Apple in May said that the majority of phones it’s selling in the U.S. are assembled in India to avoid Chinese tariffs, and although tariffs on India are going up to 25%, White House sources told CNBC that the iPhone maker will be “largely unaffected” by the India tariffs. Apple said that tariffs could cost the company $1.1 billion in the current quarter.
In 2017, Apple announced that it was creating a $1 billion manufacturing fund, which would go towards future purchase commitments with U.S. suppliers. Apple raised that to $10 billion earlier this year. Corning, one of the participants in Wednesday’s announcement, previously got two public commitments from Apple’s manufacturing fund.
In 2021, Apple said that its U.S. spending was outpacing its initial 2018 announcement. In its initial announcement, the company said it would spend $10 billion on data centers in North Carolina, Oregon, Nevada, Arizona and Iowa. Apple operates data centers in all those states today.
Apple on Wednesday said it was expanding data centers in North Carolina, Iowa, Nevada and Oregon.
WATCH: Apple’s bigger issue continues to be its missing AI, says Wedbush’s Dan Ives
-
Sports3 years ago‘Storybook stuff’: Inside the night Bryce Harper sent the Phillies to the World Series
-
Sports1 year agoStory injured on diving stop, exits Red Sox game
-
Sports2 years agoGame 1 of WS least-watched in recorded history
-
Sports2 years agoMLB Rank 2023: Ranking baseball’s top 100 players
-
Sports4 years ago
Team Europe easily wins 4th straight Laver Cup
-
Sports2 years agoButton battles heat exhaustion in NASCAR debut
-
Environment2 years agoJapan and South Korea have a lot at stake in a free and open South China Sea
-
Environment2 years agoGame-changing Lectric XPedition launched as affordable electric cargo bike